Covid fuelled substandard medical products in Indian markets: Report
While the menace of substandard and falsified (SF) medical products is not new in India, such incidents saw a significant increase during the Covid-19
While the menace of substandard and falsified (SF) medical products is not new in India, such incidents saw a significant increase during the Covid-19
The report highlights that WHO has received 1,500 reports of cases of substandard or falsified products.
